Mid-term single-center outcomes of BioIntegral compared to Freestyle aortic conduit implantation

被引:3
作者
Mehdiani, Arash [1 ]
Sorokin, Vitaly A. [2 ,3 ]
Sule, Jai [3 ]
Smiris, Konstantinos [1 ]
Stadnik, Dmytro [1 ]
Lichtenberg, Artur [1 ]
Blehm, Alexander [1 ]
机构
[1] Heinrich Heine Univ Duesseldorf, Dept Cardiovasc Surg, Dusseldorf, Germany
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore, Singapore
[3] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Cardiac Thorac & Vasc Surg, 1E Kent Ridge Rd,NUHS Tower Block,Level 9, Singapore 119228, Singapore
关键词
Aortic valve; Endovascular procedures; Blood vessel prosthesis; ACTIVE INFECTIVE ENDOCARDITIS; TERM-FOLLOW-UP; HEMODYNAMIC PERFORMANCE; VALVE-REPLACEMENT; ROOT REPLACEMENT; BIOPROSTHESIS; EXPERIENCE; SURGERY; RING;
D O I
10.23736/S0021-9509.19.11098-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Full aortic root replacement with biological conduit has limited options. This non-randomized cohort study aims to compare mid-term clinical and hemodynamic results of the BioIntegral (BI) composite biological versus the stentless Freestyle (FS) conduits in patients undergoing full aortic root replacement. METHODS: From February 2013 to July 2017, 265 patients underwent aortic root replacement at a single institution (202 BI, 65 FS). Preoperative, intraoperative and postoperative parameters, complications including stroke, myocardial infarction (MI), endocarditis and reoperation were studied. Hemodynamic performance of both conduits was analyzed by echocardiography. Target endpoints were 30-day mortality, two-year survival, two-year freedom from major adverse valve-related and cardiovascular events. RESULTS: Wider BI conduits were used (BI 27 +/- 2 vs. FS 25 +/- 2 mm, P<0.0001). The BI group had shorter cardiopulmonary bypass (BI 165 +/- 67 vs. FS 200 +/- 78 min, P<0.0001) and cross-clamp (BI 102 +/- 36 vs. FS 122 +/- 40 min, P=0.001) times. Thirty-day mortality was similar in both groups. There were fewer conduit-related reoperations in the BI group (BI 0% vs. FS 3%, P=0.012) but higher postoperative atrial fibrillation (BI 31% vs. FS 17%, P=0.025). No significant differences were observed for stroke (BI 5% vs. FS 10%, P=0.947), MI (BI 3% vs. FS 4%, P=0.583), or infective endocarditis (BI 0% vs. FS 2%, P=0.077). No significant hemodynamic differences were evident on follow-up echocardiography while an improved overall survival trend was seen in the BI group (P=0.062). CONCLUSIONS: FS and BI provide comparable clinical mid-term results and hemodynamic parameters. Simplified implantation technique providing shorter cardiopulmonary bypass and operation times are advantageous for BI.
引用
收藏
页码:512 / 519
页数:8
相关论文
共 25 条
[1]   No-react detoxification process: A superior anticalcification method for bioprostheses [J].
Abolhoda, A ;
Yu, SM ;
Oyarzun, JR ;
Allen, KR ;
McCormick, JR ;
Han, SG ;
Kemp, FW ;
Bogden, JD ;
Lu, Q ;
Gabbay, S .
ANNALS OF THORACIC SURGERY, 1996, 62 (06) :1724-1730
[2]  
Auffret Vincent, 2016, J Heart Valve Dis, V25, P543
[3]  
Baumgartner H, 2018, EUR HEART J, V39, P1980, DOI [10.1093/eurheartj/ehx636, 10.1093/eurheartj/ehx391]
[4]  
Beckerman Ziv, 2018, J Vis Surg, V4, P98, DOI 10.21037/jovs.2018.04.05
[5]  
BioIntegral Surgical, 2016, BIOCONDUIT
[6]  
Blehm A, 2015, J HEART VALVE DIS, V24, P540
[7]  
Blehm A, 2014, J HEART VALVE DIS, V23, P9
[8]   Evaluation of Hemodynamic Performance of Aortic Valve Bioprostheses in a Model of Oversizing [J].
Cleveland, John D. ;
Bowdish, Michael E. ;
Eberhardt, Carol E. ;
Mack, Wendy J. ;
Crabtree, James A. ;
Vassiliades, Thomas A. ;
Speir, Alan M. ;
Darekar, Yogesh A. ;
Hackmann, Amy E. ;
Starnes, Vaughn A. ;
Cohen, Robbin G. .
ANNALS OF THORACIC SURGERY, 2017, 103 (06) :1866-1877
[9]  
De Paulis Ruggero, 2018, J Vis Surg, V4, P94, DOI 10.21037/jovs.2018.04.12
[10]  
Di Eusanio M, 2014, MULTIMED MAN CARDIOT, V2014, P2014